AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Clinical trials for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug AZD1613 tested for kidney cyst disease
Disease control Recruiting nowThis early-stage study tests the safety of a new drug called AZD1613 in 40 adults with autosomal dominant polycystic kidney disease (ADPKD), a condition where cysts grow in the kidneys. Participants receive either the drug or a placebo to see how the body handles it and if any si…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 05:19 UTC
-
Diabetes drug metformin tested as lifeline for polycystic kidney patients
Disease control Recruiting nowThis study tests whether metformin, a widely used diabetes medication, can slow the loss of kidney function in people with early-stage autosomal dominant polycystic kidney disease (ADPKD). About 1,174 adults aged 18–70 with mild to moderate kidney decline will receive either metf…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Phase: PHASE3 • Sponsor: The University of Queensland • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug aims to shrink cysts in genetic kidney disease
Disease control Recruiting nowThis study tests an investigational drug called ABBV-CLS-628 in adults with autosomal dominant polycystic kidney disease (ADPKD), a genetic condition that causes fluid-filled cysts to grow in the kidneys. The goal is to see if the drug can safely slow the increase in kidney size …
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
New biomarkers could help track kidney disease early
Knowledge-focused Recruiting nowThis study aims to find out if certain substances in urine and blood can help measure how severe kidney disease is in people with early autosomal dominant polycystic kidney disease (ADPKD). Researchers will collect samples from 60 participants aged 15 to 40 and use MRI to measure…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC
-
Diabetes drug may unlock kidney mineral mysteries in cystic disease
Knowledge-focused Recruiting nowThis study looks at how Empagliflozin, a diabetes drug, changes the way the kidneys handle calcium, phosphate, and magnesium in people with autosomal dominant polycystic kidney disease (ADPKD). About 40 adults will take either the drug or a placebo for 2 weeks, then switch after …
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: Cantonal Hospital Graubuenden • Aim: Knowledge-focused
Last updated May 19, 2026 12:01 UTC
-
New study seeks clues to slow kidney disease progression
Knowledge-focused Recruiting nowThis study looks at how the body handles oxidative stress in people with early-stage autosomal dominant polycystic kidney disease (ADPKD). Researchers will measure markers of damage and antioxidant activity in blood and urine, and use MRI to measure kidney size. The goal is to fi…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC